[go: up one dir, main page]

MX2017007969A - Bacterias de acido lactico y su uso para el tratamiento de mastitis. - Google Patents

Bacterias de acido lactico y su uso para el tratamiento de mastitis.

Info

Publication number
MX2017007969A
MX2017007969A MX2017007969A MX2017007969A MX2017007969A MX 2017007969 A MX2017007969 A MX 2017007969A MX 2017007969 A MX2017007969 A MX 2017007969A MX 2017007969 A MX2017007969 A MX 2017007969A MX 2017007969 A MX2017007969 A MX 2017007969A
Authority
MX
Mexico
Prior art keywords
lactic acid
acid bacteria
mastitis
treatment
lactobacillus reuteri
Prior art date
Application number
MX2017007969A
Other languages
English (en)
Inventor
Connolly Eamonn
Möllstam Bo
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of MX2017007969A publication Critical patent/MX2017007969A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)

Abstract

La presente invención se refiere a novedosas cepas de bacterias de ácido láctico Lactobacillus reuteri seleccionadas del grupo que comprende Lactobacillus reuteri DSM 32229, Lactobacillus reuteri DSM 32230, Lactobacillus reuteri DSM 32231 y Lactobacillus reuteri DSM 32232 y productos que comprenden estas cepas. La presente invención también se refiere al uso de una o más cepas de bacterias de ácido láctico como un probiótico para el tratamiento de una inflamación e infección, tal como mastitis y/o ubrera, en especial después de la administración tópica de dichas cepas.
MX2017007969A 2015-01-16 2016-01-14 Bacterias de acido lactico y su uso para el tratamiento de mastitis. MX2017007969A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562104164P 2015-01-16 2015-01-16
PCT/EP2016/050699 WO2016113365A1 (en) 2015-01-16 2016-01-14 Lactic acid bacteria and their use for the treatment of mastitis

Publications (1)

Publication Number Publication Date
MX2017007969A true MX2017007969A (es) 2018-04-10

Family

ID=56405271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007969A MX2017007969A (es) 2015-01-16 2016-01-14 Bacterias de acido lactico y su uso para el tratamiento de mastitis.

Country Status (12)

Country Link
US (2) US20180273895A1 (es)
EP (1) EP3244904A1 (es)
JP (1) JP2018504902A (es)
KR (1) KR20170103804A (es)
CN (1) CN107532137A (es)
AU (1) AU2016208009A1 (es)
BR (1) BR112017014225A2 (es)
CA (1) CA2972967A1 (es)
CL (1) CL2017001818A1 (es)
HK (1) HK1248756A1 (es)
MX (1) MX2017007969A (es)
WO (1) WO2016113365A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700062260A1 (it) * 2017-06-07 2018-12-07 Proge Farm Srl Associazione e composizioni topiche cutanee comprendenti lattobacilli e ossidi metallici e/o semimetallici
WO2020132098A1 (en) * 2018-12-19 2020-06-25 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
AU2020352646B2 (en) * 2019-09-26 2025-09-04 Precisionbiotics Group Limited Lactobacillus reuteri
US20230241134A1 (en) * 2020-06-30 2023-08-03 Biogaia Ab Probiotic composition for topical use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
MY188015A (en) * 2011-12-30 2021-11-09 Abbott Lab Concentrated low water activity liquid human milk fortifier including extensively hydrolyzed protein

Also Published As

Publication number Publication date
KR20170103804A (ko) 2017-09-13
JP2018504902A (ja) 2018-02-22
AU2016208009A1 (en) 2017-07-20
CL2017001818A1 (es) 2018-03-02
BR112017014225A2 (pt) 2018-03-06
CA2972967A1 (en) 2016-07-21
HK1248756A1 (zh) 2018-10-19
EP3244904A1 (en) 2017-11-22
US20200318061A1 (en) 2020-10-08
WO2016113365A1 (en) 2016-07-21
CN107532137A (zh) 2018-01-02
US20180273895A1 (en) 2018-09-27

Similar Documents

Publication Publication Date Title
WO2016179440A3 (en) Antimicrobial therapy
IL291460A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
EP4293033A3 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX2015011700A (es) Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion.
MX2019011058A (es) Moleculas probioticas para reducir virulencia patogena.
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
EP3584308A3 (en) Compositions and methods
PT4031157T (pt) Estirpes bacterianas, suas composições e sua utilização para o tratamento de perturbações gastrointestinais
MX2017016748A (es) Bacteria lactobacillus rhamnosus para el tratamiento de, por ejemplo, vaginosis bacteriana.
MX2020006191A (es) Bacteriocinas terapeuticas.
MY193248A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX382895B (es) Suplemento dietético.
EP4268897A3 (en) Minocycline compounds for biodefense
PH12018500358A1 (en) Compounds for use in an antibacterial applications
PH12019501439B1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
MX2018007838A (es) Silice recubierta de mucina para acumulacion bacteriana.
MX2019006086A (es) Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados.
MX2020001501A (es) Streptococcus australis como bioterapeuticos.
WO2020120716A8 (en) Compositions comprising bacterial strains
PL414701A1 (pl) Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.